However, in Botswana as well as elsewhere in sub-Saharan Africa, over half of CM cases now occur in ART-experienced patients14–16, and reflex screening where CD4 monitoring is conducted is now identifying an important number of ART-experienced and CrAg-positive patients. Here, AGAP3 is linked to cutaneous mastocytosis.